GHRS GH Research PLC
Company Analysis
Latest News
🟢 GH Research is trading 5.6% up today amid broader biotech-sector gains
GH Research is trading at $19.31, up 5.63%, apparently in line with biotech-sector strength; no direct company-specific cause has been identified. - XBI rose...
🔴 GH Research is trading 5.5% down today amid a 2.01% XBI session decline
GH Research is trading at $18.91, down 5.54%, with biotech-sector weakness the likeliest available context. - XBI was down 2.01% during the session, though...
🔴 GH Research is trading 5% down — no clear catalyst identified
GH Research is trading 5.16% down at $20.02, with no clear catalyst identified for the October 12 decline. - The available company announcement disclosed...
🔴 GH Research is trading 5% down today with sector weakness the likeliest context
GH Research is trading at $20.00, down 5.03%, with biotech-sector weakness the likeliest context. - No clear GH Research-specific announcement or catalyst...
🔴 GH Research is trading 5.5% down in pre-market with no clear company-specific catalyst identified
GH Research is trading at $20.95, down 5.5% in pre-market on October 6, 2026; no clear company-specific catalyst has been identified. - Shares closed at $22.17...
🟢 GH Research is trading 5% up in pre-market
GH Research is trading 5.01% higher at $23.28 before the October 6, 2026 session; no clear catalyst has been established. - The previous close was $22.17;...
🔴 GH Research is trading 5% down as catalyst remains unclear
GH Research is trading 5.27% lower at $23.37 on September 30, 2026, with the catalyst unclear. - The stock gained 5.34% on September 29, closing at $24.67. -...
🟢 GH Research is trading 5% up — catalyst remains unclear
GH Research is trading at $24.64, up 5.23%, with the catalyst for the September 29 move unclear based on available reporting. - The company’s...
🔴 GH Research is trading at 5.2% down today as higher-for-longer interest rates pressure biotech stocks
GH Research is trading 5.2% down at $24.61 as elevated Treasury yields and persistent inflation concerns intensify risk-off pressure on growth-oriented...
🔴 GH Research is trading at 5.6% down today as oil, yields and inflation concerns pressure markets
GH Research is trading 5.62% lower at $26.30, primarily amid broad risk-off pressure across markets. - Major U.S. indexes are lower as oil, Treasury yields,...
🟢 GH Research is trading 0.3% up in pre-market with no clear company-specific catalyst
GH Research is trading 0.3% up at $27.63, with no clear company-specific catalyst identified for September 16. - It closed at $27.55 on September 15, 2026. -...
🔴 GH Research is trading 7.14% down in after-hours trading with no clear company-specific catalyst
GH Research is trading 7.14% down at $25.90 in after-hours trading after closing at $27.89 on September 14, 2026, with no clear company-specific catalyst. -...
🟢 GH Research is trading 6.7% up in pre-market; catalyst remains uncertain
GH Research is trading 6.7% up now at $29.41, with no fresh company announcement clearly explaining the September 10, 2026 pre-market move. - It rose from the...
🟢 GH Research is trading 4.2% up today amid tentative broader risk-on sentiment
GH Research is trading 4.2% up at $29.37, with coverage tentatively pointing to broader risk-on sentiment following cooler inflation data. - The move reverses...
🟢 GH Research is trading 5.78% up in pre-market amid tentative risk-on sentiment after cooler-than-expected inflation data
GH Research is trading 5.78% up now at $29.82, apparently amid broader risk-on sentiment after cooler-than-expected inflation data; confidence in this...
🔴 GH Research is trading 4.3% down today despite broader U.S. equities moving higher
GH Research is trading 4.3% down now at $28.93, despite broader U.S. equities moving higher on August 13, 2026, after softer-than-expected July PPI and easing...
🟢 GH Research is trading 4.13% up today amid broader risk-on sentiment and July CPI expectations
GH Research is trading up 4.13% at $30.28 amid broader risk-on sentiment as U.S. equities move higher around July CPI expectations. - The Nasdaq Composite is...
🟢 GH Research is trading 5% up in pre-market after GH001 Phase 3 readiness update
GH Research is trading 4.93% up now at $31.76 after its August 6, 2026, earnings release highlighted Phase 3 readiness for GH001. - FDA responses indicated...
🟢 GH Research is trading 5% up today after narrower-than-expected loss, Phase 3-ready FDA feedback
GH Research is trading 5.46% up at $30.72 after reporting a second-quarter loss of $0.23 per share, narrower than the $0.31 consensus estimate. - FDA feedback...
GH Research second quarter loss of $0.23 per share beats estimates as the company prepares for its Phase 3 trial.
GH Research PLC reported no revenue and a net loss of $15.1 million, or $0.23 per share, for the second quarter of 2026. The loss per share was smaller than...